Breaking New Ground: Clinical Innovation in Mental Health and Substance Use Disorders

A new wave of clinical innovation is reshaping the treatment landscape for individuals with complex and difficult to treat illness such as schizophrenia and opioid use disorder, creating opportunities to improve outcomes, expand access to care, and address persistent treatment gaps. As emerging therapies gain traction, important questions remain about how to ensure these innovations reach the people who need them, including opportunities for coverage and reimbursement, both by private insurance and Medicare/Medicaid, as well as real-world implementation challenges.

In this one-hour virtual panel discussion, moderated by Manatt Health, panelists will examine the latest treatment innovations across digital health and pharmaceutical therapies, share real-world experiences with implementation and coverage, and explore strategies to advance access, quality, and outcomes for Medicaid beneficiaries living with serious mental health conditions and substance use disorders.

Panelists:

• , MD, Senior Advisor, Manatt Health – Moderator
• Cassandra Snipes, PhD, Head of Science, Click Therapeutics
• Sam Wilson, Chief Executive Officer, Opio Connect
• Steve Levine, MD, Chief Patient Officer, Compass Pathways

Click to register and submit questions in advance.